The role of reference pathology to assess MRI-TRUS fusion prostate biopsies in a tertiary referral center.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.32
Abstract: 32Background: Risk stratification for patients diagnosed with prostate cancer (PCa) through MR-TRUS fusion biopsy still relies on Gleason (GL) grading of the biopsy specimens. GL grading of the same sample can differ between pathologists. In… read more here.
Keywords: trus fusion; biopsy; reference pathology; pathology ... See more keywords